USTR Announces Initiation of Section 301 Investigation of Germany’s Persistent Underpayment for Innovative Pharmaceutical Products
USTR Announces Initiation of Section 301 Investigation of Germany’s Persistent Underpayment for Innovative Pharmaceutical Products pbrouillette Thu, 06/18/2026 - 20:36 WASHINGTON – Today, U.S. Trade…
Read the full articleYou might also wanna read
U.S. launches tariff probe into Germany's pharmaceutical pricing policies
U.S. Trade Representative Jamieson Greer said Germany's proposal to reduce spending on medicines was "a serious step backwards."
cnbc.com·21d ago
U.S.-Brazil: 37.5% tariff threat looms
The Office of the United States Trade Representative (USTR) is expected next week to unveil a new round of import tariffs and identify the p
USTR Special 301 Report Upholds Intellectual Property as US Trade Priority
RIAA SVP International Policy George York Lauds Findings WASHINGTON, DC (May 1, 2026) – The US Trade Representative (USTR)’s annual Special
USTR Proposes Section 301 Tariffs on 60 Economies Over Forced Labor Enforcement, Raising Questions About Motives
The USTR's proposed Section 301 tariffs are intended more to pressure countries to sign and implement deals than to protect labor.
justsecurity.org·24d ago
Brazil’s meeting with U.S. officials included talks on transnational crime
Márcio Rosa: “What we’re discussing covers all the issues tied to Section 301—pushing back on the lack of merit in the criticisms around def
Free Market Groups, Advocates Oppose Codification of Most-Favored-Nation Drug Pricing
February 12th, 2026 The Honorable Members United States Congress Washington, D.C. 20515 RE: Coalition Opposing the Codification of Most-Favo
Comments
Sign in to join the conversation.
No comments yet. Be the first.